MRNA · Moderna, Inc.
AI read · Bad for MRNA
The AI's read
Moderna plunged about 25% today after handing back gains following a 176.97% spike on positive Phase 3 cancer vaccine results. That flip matters because a massive reversal on heavy volume signals short-term sellers and profit-taking. The market has already moved hard: MRNA is down ~23.6% intraday with huge volume, so a large portion of the move is priced. Short interest around 12.5% of float raises the odds of volatile follow-through. We lean bearish since the price action shows clear downside pressure and the move is already underway. Conviction 90% but volatility is extreme, expect quick reversals.